Tetra Bio Pharma ready to lead in cannabinoid drug development

Tetra Bio Pharma (CVE:TBD- TBPMF:OTCMKTS) Robert Béchard , Executive Vice President, Corporate Development and Licensing joined Steve Darling from Proactive Investors to talk about his company that is billed as a biopharmaceutical leader in cannabinoid-based drug discovery and development with a clinical program aimed at bringing novel drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries that are engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.


Leave a Reply

Your email address will not be published. Required fields are marked *